The tech giant is aiming to get on a strong competitive footing against Amazon and Microsoft, but experts say the tech faces challenges in the world of medicine.
Alex Rives, the research lead of Meta’s former AI protein team, is interim CEO for new startup EvolutionaryScale, which is developing biological large language models.
The market’s obsession with data science and artificial intelligence is reflected in this year’s list of 25 companies we think most likely to reach $1 billion valuation.
New study by the St Gallen consortium estimates the cost of one approved drug at $6.16 Billion. 7 of the top 16 pharma companies demonstrated negative R&D productivity.
OpenEvidence, which is valued at $425 million, is taking on one of AI’s big engineering challenges: large language models whose training is stuck in the past.
Amazon is continuing its expansion into the health space with the launch of a new generative AI tool called HealthScribe, meant to take over some time-consuming administrative tasks of doctor’s offices and clinics, the company said.
With a new $59 million investment, digital health startup K Health is looking to scale its AI technology in hospitals, starting with new strategic investor Cedars-Sinai.